Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Open-label extension study of levoketoconazole for endogenous Cushing syndrome
MOH_2018-09-25_003661Phase 3Not yet recruiting
- Sponsor
- Strongbridge Biopharma
- Start
- Sep 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of levoketoconazole in endogenous Cushing's syndrome, sponsored by Strongbridge Biopharma. Planned start Sep 2018; status: not yet recruiting.
02
Drugs
levoketoconazole
03
Conditions
endogenous Cushing's syndrome
Beyond the preview
Go deeper on MOH_2018-09-25_003661.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on MOH_2018-09-25_003661.